Liposomal amphotericin B for fungal infections in transplant patients
Treatments studied
Part of Infections clinical trials.
This study looks at how well a medicine called liposomal amphotericin B works for treating serious fungal infections in people who have had a solid organ transplant. It may help doctors understand the best way to use this medicine for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have received a solid organ transplant (like a kidney, liver, heart, or lung).
- You have been diagnosed with a serious fungal infection that is inside your body.
- You are already receiving a specific antifungal medicine called liposomal amphotericin B as part of your regular care.
- You do not have severe liver or kidney problems that would make this treatment unsafe.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This trial tests the safety and effectiveness of a medicine called liposomal amphotericin B for treating serious mold infections in liver transplant recipients. It compares this medicine to another antifungal called voriconazole, and may help find the best way to treat these infections after a liver transplant.
This trial tests amphotericin B (an antifungal medication) in patients with blood cancers who develop a fungal infection despite already taking antifungal preventive medicine. The study aims to see if this medication can treat these hard-to-treat infections.
This trial studies how the body processes the antifungal drug liposomal amphotericin B (L-AmB) in patients on ECMO (a heart-lung machine). The goal is to find the right dose for treating invasive fungal infections in ICU patients who need ECMO support.
This trial studies how liposomal amphotericin B (a drug used to treat serious fungal infections) moves through the body in people who are critically ill versus those who are not. It may help doctors choose safer and more accurate dosing for patients with blood-related illnesses.
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
Hear when a new Solid Organ Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.